6.
Lo J, Yu C, Chiou S, Huang C, Jan C, Lin S
. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Res. 2010; 71(5):1912-23.
DOI: 10.1158/0008-5472.CAN-10-2350.
View
7.
Zhang J, Sarkar S, Cua R, Zhou Y, Hader W, Yong V
. A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis. Carcinogenesis. 2011; 33(2):312-9.
DOI: 10.1093/carcin/bgr289.
View
8.
Bras J, Bravo J, Freitas J, Barbosa M, Santos S, Summavielle T
. TNF-alpha-induced microglia activation requires miR-342: impact on NF-kB signaling and neurotoxicity. Cell Death Dis. 2020; 11(6):415.
PMC: 7265562.
DOI: 10.1038/s41419-020-2626-6.
View
9.
Cooper L, Gutman D, Chisolm C, Appin C, Kong J, Rong Y
. The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma. Am J Pathol. 2012; 180(5):2108-19.
PMC: 3354586.
DOI: 10.1016/j.ajpath.2012.01.040.
View
10.
Wischhusen J, Melero I, Fridman W
. Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint. Front Immunol. 2020; 11:951.
PMC: 7248355.
DOI: 10.3389/fimmu.2020.00951.
View
11.
Meng Q, Ying Z, Noble E, Zhao Y, Agrawal R, Mikhail A
. Systems Nutrigenomics Reveals Brain Gene Networks Linking Metabolic and Brain Disorders. EBioMedicine. 2016; 7:157-66.
PMC: 4909610.
DOI: 10.1016/j.ebiom.2016.04.008.
View
12.
Bazzocco S, Dopeso H, Martinez-Barriocanal A, Anguita E, Nieto R, Li J
. Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome-wide promoter hypermethylation analysis. Clin Epigenetics. 2021; 13(1):88.
PMC: 8063439.
DOI: 10.1186/s13148-021-01070-0.
View
13.
Popiolek-Barczyk K, Ciechanowska A, Ciapala K, Pawlik K, Oggioni M, Mercurio D
. The CCL2/CCL7/CCL12/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system in microglia. Mol Cell Probes. 2020; 54:101671.
DOI: 10.1016/j.mcp.2020.101671.
View
14.
Shi C, Pamer E
. Monocyte recruitment during infection and inflammation. Nat Rev Immunol. 2011; 11(11):762-74.
PMC: 3947780.
DOI: 10.1038/nri3070.
View
15.
Kim Y, Varn F, Park S, Yoon B, Park H, Lee C
. Perspective of mesenchymal transformation in glioblastoma. Acta Neuropathol Commun. 2021; 9(1):50.
PMC: 7992784.
DOI: 10.1186/s40478-021-01151-4.
View
16.
Hu J, Luo W, Wang H
. Angiogenin Upregulation Independently Predicts Unfavorable Overall Survival in Proneural Subtype of Glioblastoma. Technol Cancer Res Treat. 2019; 18:1533033819846636.
PMC: 6515846.
DOI: 10.1177/1533033819846636.
View
17.
Min K, Liggett J, Silva G, Wu W, Wang R, Shen R
. NAG-1/GDF15 accumulates in the nucleus and modulates transcriptional regulation of the Smad pathway. Oncogene. 2015; 35(3):377-88.
PMC: 4613816.
DOI: 10.1038/onc.2015.95.
View
18.
Verhaak R, Hoadley K, Purdom E, Wang V, Qi Y, Wilkerson M
. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010; 17(1):98-110.
PMC: 2818769.
DOI: 10.1016/j.ccr.2009.12.020.
View
19.
Tatard V, Xiang C, Biegel J, Dahmane N
. ZNF238 is expressed in postmitotic brain cells and inhibits brain tumor growth. Cancer Res. 2010; 70(3):1236-46.
DOI: 10.1158/0008-5472.CAN-09-2249.
View
20.
Masilamani A, Schulzki R, Yuan S, Haase I, Kling E, Dewes F
. Calpain-mediated cleavage generates a ZBTB18 N-terminal product that regulates HIF1A signaling and glioblastoma metabolism. iScience. 2022; 25(7):104625.
PMC: 9253709.
DOI: 10.1016/j.isci.2022.104625.
View